Voyager Therapeutics

Cambridge, United States

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

$100.0M raised

Jan 2024

Post-IPO Equity

Biotechnology Genetics Health Care Life Science

Top Investors

Wellington Management Third Rock Ventures Fidelity Deerfield Casdin Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Voyager Therapeutics

How much funding has Voyager Therapeutics raised?

Voyager Therapeutics has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.

Who are Voyager Therapeutics's investors?

Voyager Therapeutics's investors include Wellington Management, Third Rock Ventures, Fidelity, Deerfield, Casdin Capital.

Where is Voyager Therapeutics headquartered?

Voyager Therapeutics is headquartered in Cambridge, United States.

What does Voyager Therapeutics do?

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

What stage is Voyager Therapeutics at?

Voyager Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 4, 2024.

MLA

"Voyager Therapeutics — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/voyager-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Voyager Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/voyager-therapeutics

Wikipedia (cite web)

{{cite web |title=Voyager Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/voyager-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 4, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K